Psychiatric treatment in men with prostate cancer ? Results from a Nation-wide, population-based cohort study from PCBaSe Sweden.
Eur J Cancer. 2011 May 23;
Authors: Bill-Axelson A, Garmo H, Nyberg U, Lambe M, Bratt O, Stattin P, Adolfsson J, Steineck G
AIM: To explore whether the self-reported psychological distress among men with prostate cancer was to the extent that it required psychiatric treatment. METHODS: PCBaSe Sweden, a merged database based on the National Prostate Cancer Register including 97% of all prostate cancers registered as well as age-matched controls. We calculated relative risks and 95% confidence intervals to compare risks of psychiatric treatment due to depression, anxiety, and post-traumatic stress disorder controlling for age and socio-economic factors. We used odds ratios to compare use or no use of antidepressants. FINDINGS: In total 72,613 men with prostate cancer and 217,839 men without prostate cancer were included for analyses. Psychiatric hospitalisation due to depression, anxiety and post-traumatic stress disorder were significantly increased (RR 1.29, (95% CI 1.14-1.45), RR 1.42 (95% CI 1.12-1.80) and RR 1.61 (95% CI 1.16-2.24), respectively). However, hospitalisations due to anxiety were only increased in men with more advanced tumours RR 2.28 (95% CI 1.45-3.57). The use of antidepressants was increased for all men with prostate cancer RR 1.65 (95% CI 1.54-1.77) and treatment strategies RR 1.93 (95% CI 1.75-2.13). INTERPRETATION: Men diagnosed with prostate cancer had increased risk of psychiatric treatment for depression, post-traumatic stress disorder and use of antidepressants regardless of risk group and treatment strategy compared to age-matched controls, whilst more advanced prostate cancer was associated with severe anxiety disorders.
PMID: 21612913 [PubMed - as supplied by publisher]
Go to Source
lance armstrong sammy sosa ethanol iceland volcano eruption justin timberlake snl air force one lacrosse
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.